While Tilray has maintained its leading market share in the recreational cannabis market in Canada and the medical cannabis market in Europe, its Q2 earnings, which included a loss per share of -$0.11 and an adjusted loss per share of -$0.06, have left investors questioning the company's future growth prospects.

Today we're looking at two penny stocks that will perform well this week.

The cannabis industry is fragmented following state legalization over the past decade.

With the acquisition of Breckenridge Distillery, Tilray is undergoing a horizontal expansion to increase its offering in the beverage alcohol sector.

Let’s take a look at a couple of cannabis stocks that are off to a hot start in February.

When is the right time to buy stock in the cannabis market? The time is now!

Here's what analysts' are forecasting for Tilray's Q2 earnings report on Monday.